12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Elutia (NASDAQ:ELUT) stock rose 24.2% to $4.31 during Tuesday’s regular session. The market value of their outstanding…
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Cue Health (NASDAQ:HLTH) stock moved upwards by 32.4% to $0.12 during Monday’s pre-market session. The market value…
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Cue Health (NASDAQ:HLTH) shares moved upwards by 42.1% to $0.13 during Friday’s pre-market session. The company’s market…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Predictive Oncology (NASDAQ:POAI) shares rose 36.4% to $1.95 during Tuesday’s after-market session. The company’s market cap stands…
Akari Therapeutics Presents Poster On Progress In Pre-Clinical Development Of Long-Acting PAS-Nomacopan As A Potential Treatment For Geographic Atrophy At The 4th Annual Dry AMD Therapeutic Development Conference
Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the presentation of progress in the development of
Akari Therapeutics To Present A Poster On Pre-Clinical Development Of Long-Acting PAS-Nomacopan As A Potential Treatment For Geographic Atrophy At The 4th Annual Dry AMD Therapeutic Development Conference
Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that Chief Scientific Officer Miles Nunn will present a
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 16.7% to $0.42 during Monday’s after-market session. Today’s trading volume for…
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Bio-Path Hldgs (NASDAQ:BPTH) stock rose 132.2% to $0.92 during Friday’s pre-market session. The company’s market cap stands…
Akari Therapeutics Announces Existing Investors Support The Company Through A $2M Private Placement Financing, Company Also Receives $2.5M U.K. R&D Tax Credit
Akari Therapeutics, Plc (NASDAQ:AKTX) ("Akari" or the "Company"), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that it has entered into
Why NICE Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
PhenomeX Inc. (NASDAQ: CELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 million definitive agreement for Bruker to acquire PhenomeX in an all-cash transaction for $1 per share.